Evidence map›Paper›PMID 37754819›Full record

ReviewJournal of cardiovascular development and disease2023

β

Akane Kawai, Yuji Nagatomo, Midori Yukino-Iwashita, Ryota Nakazawa, Akira Taruoka, Yusuke Yumita, Asako Takefuji, Risako Yasuda, Takumi Toya, Yukinori Ikegami and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Journal of cardiovascular development and disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Akane KawaiDepartment of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan.ORCID 0009-0002-5218-7631
Yuji NagatomoDepartment of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan.ORCID 0000-0002-3430-4614
Midori Yukino-IwashitaDepartment of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan.
Ryota NakazawaDepartment of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan.
Akira TaruokaDepartment of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan.
Yusuke YumitaDepartment of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan.
Asako TakefujiDepartment of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan.
Risako YasudaDepartment of Intensive Care, National Defense Medical College, Tokorozawa 359-8513, Japan.
Takumi ToyaDepartment of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan.ORCID 0000-0002-4681-2798
Yukinori IkegamiDepartment of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan.
Nobuyuki MasakiDepartment of Intensive Care, National Defense Medical College, Tokorozawa 359-8513, Japan.
Yasuo IdoDepartment of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan.
Takeshi AdachiDepartment of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan.
National Defense Medical College · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A wide range of anti-myocardial autoantibodies have been reported since the 1970s. Among them, autoantibodies against the β

Indexed as

dilated cardiomyopathyheart failureimmunoadsorptionβ1 adrenergic receptor autoantibody

Identifiers

PMID37754819
PMCPMC10531529
OpenAlexW4386608171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.